Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
基本信息
- 批准号:8538296
- 负责人:
- 金额:$ 44.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAmericanAntioxidantsApoptosisApoptoticAzoxymethaneBenchmarkingBindingBiological AssayBiological MarkersBotanicalsCancer EtiologyCell Culture SystemCell DeathCell LineCell ProliferationCellsCessation of lifeChemopreventionChemopreventive AgentChromatinClinicalClinical TrialsColonColon CarcinomaColorectal CancerCoupledCurcuma longaCurcuminDNA Methyltransferase InhibitorDeoxycytidineDiagnosisDiseaseEffectivenessEnzymesEpidermal Growth Factor ReceptorEpigenetic ProcessEventFutureGene Expression RegulationGene TargetingGenesGoalsHT29 CellsHistone Deacetylase InhibitorHistone H3HumanHypermethylationIn VitroInduction of ApoptosisIntestinesLNCaPLeukotriene B4MAPK8 geneMalignant NeoplasmsMalignant neoplasm of prostateMessenger RNAMethyl-CpG-Binding Protein 2MethylationModificationMolecularMusNQO1 geneNude MiceOxidative StressPhasePlant RootsPreventionProstatic NeoplasmsProteinsPublishingRegimenReportingResearch Project GrantsSignal PathwaySiteSodium Dextran SulfateTherapeuticTrichostatin ATumor SuppressionUGT1A1 geneWomanXenograft procedureadenomaagedanalogbasecancer cellcancer chemopreventioncancer preventioncost effectivedemethoxycurcumindesigndibenzoylmethanedietary supplementsdisorder preventionfeedinghuman FRAP1 proteinin vivomenmortalitymouse modelneoplastic cellpreventpromoterprostate cancer preventionprostate carcinogenesissuccesstranscription factortumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The products of root of Curcuma longa (C.L.), usually contain three major components, curcumin (CUR; ~77%), demethoxycurcumin (~17%) and bis-demethoxycurcumin (~3%), they are commonly used as botanical dietary supplements. The long term goal of this research project is to develop a safe and effective strategy to use C.L. in preventing diseases including prostate cancer (PCa) and colorectal cancer (CRC) in the US. PCa remains the most common malignancy in American men with an estimated 192,280 new cases and 27,360 deaths were expected in 2009, whereas CRC is the second most common cause of cancer death among men ages 40 to 79 years, and the third leading cause of cancer mortality in women with an estimated 53,439 new cases were diagnosed in 2010. Rationale for the studies proposed in this application is derived from our published as well as preliminary unpublished studies demonstrating that: (1) in PCa, CUR shows in vivo inhibition of prostate tumors in nude mice human PC-3 xenograft and TRAMP mice; (2) in CRC, CUR induces apoptosis in human HT-29 colon cancer cells and inhibits NFkB; an analog of CUR dibenzoylmethane, inhibits adenomas in APCmin mice, and CRC in AOM-DSS mice; (3) CUR regulate Nrf2-dependent genes in the intestine using Nrf2 KO mice; (4) As TRAMP mouse PCa progresses, there is a loss of the anti-oxidative stress transcription factor Nrf2 and Nrf2-target genes; (5) Feeding TRAMP mice with CUR resulted in re-expression of Nrf2 and Nrf2-target gene UGT1A1 in the TRAMP prostate tumor correlating with tumor suppression; (6) Nrf2 gene is epigenetically regulated in TRAMP tumor and TRAMP C1 cell line through promoter CpG hypermethylation; (7) CUR reverses the methylation status of genes from a panel of 96 gene promoters of which their hypermethylation has been reported in human PCa; (8) CUR reverses the expression of Neurog1 gene, an established cancer methylation marker gene, with increase in de-methylation of Neurog1 gene coupled with increase Neurog1 mRNA and protein. Despite these promising results, however, significant gaps exist in our understanding of the epigenetic mechanisms of CUR/C.L. in disease prevention including cancer prevention of human PCa and CRC. Based on the results of our preliminary studies we hypothesize that C.L./CUR treatment causes epigenetic modifications leading to prevention of PCa and CRC with three Specific Aims: (1) To determine the epigenetic alterations elicited by Curcuma Longa (C.L.) in prevention of prostate tumorigenesis in TRAMP mice; (2) To investigate the chemopreventive efficacy and epigenetic alterations of C.L. in AOM/DSS-induced CRC; and (3) To elucidate the in vitro epigenetic mechanisms of regulation of the genes obtained from in vivo Aims one and two by C.L. in TRAMP C1, LNCaP, and HT29 cell culture system.
性状(由申请人提供):姜黄(Curcuma longa(C.L.))根的产物,通常含有三种主要成分,姜黄素(CUR;约77%),脱甲氧基姜黄素(约17%)和双脱甲氧基姜黄素(约3%),它们通常用作植物性膳食补充剂。本研究项目的长期目标是开发一种安全有效的使用C. L.在预防疾病,包括前列腺癌(PCa)和结直肠癌(CRC)在美国。PCa仍然是美国男性中最常见的恶性肿瘤,2009年预计有192,280例新发病例和27,360例死亡,而CRC是40至79岁男性癌症死亡的第二大常见原因,并且是女性癌症死亡的第三大原因,2010年诊断出估计有53,439例新发病例。在本申请中提出的研究的基本原理源自我们已发表的以及未发表的初步研究,其证明:(1)在PCa中,CUR显示出对裸鼠人PC-3异种移植物和TRAMP小鼠中前列腺肿瘤的体内抑制;(2)在CRC中,CUR诱导人HT-29结肠癌细胞的凋亡并抑制NF κ B; CUR二苯甲酰甲烷的类似物,抑制APCmin小鼠中的腺瘤和AOM-DSS小鼠中的CRC;(3)CUR调节使用Nrf 2 KO小鼠的肠中的Nrf 2依赖性基因;(4)随着TRAMP小鼠PCa的进展,存在抗氧化应激转录因子Nrf 2和Nrf 2靶基因的丢失;(5)用CUR喂养TRAMP小鼠导致TRAMP前列腺肿瘤中Nrf 2和Nrf 2靶基因UGT 1A 1的重新表达,与肿瘤抑制相关;(6)Nrf 2基因在TRAMP肿瘤和TRAMP C1细胞系中通过启动子CpG超甲基化进行表观遗传调控;(7)CUR逆转了来自一组96个基因启动子的基因的甲基化状态,其中它们在人类PCa中已被报道过甲基化;(8)CUR逆转了已建立的癌症甲基化标记基因Neurog 1基因的表达,Neurog 1基因的去甲基化增加,同时Neurog 1 mRNA和蛋白质增加。尽管有这些有希望的结果,但是,我们对CUR/C.L.的表观遗传机制的理解存在重大差距。在疾病预防中,包括人PCa和CRC的癌症预防。根据我们初步研究的结果,我们假设C.L./ CUR治疗引起表观遗传修饰,导致PCa和CRC的预防,具有三个特定目的:(1)确定由姜黄(C.L.)(2)研究C.L. AOM/DSS诱导的CRC;(3)阐明C.L.在TRAMP C1、LNCaP和HT 29细胞培养系统中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ah-Ng Tony Kong其他文献
Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models
植物化学物对癌症的化学预防:潜在的分子靶点、生物标志物和动物模型
- DOI:
10.1111/j.1745-7254.2007.00694.x - 发表时间:
2007-09-01 - 期刊:
- 影响因子:8.400
- 作者:
Ki Han Kwon;Avantika Barve;Siwang Yu;Mou-Tuan Huang;Ah-Ng Tony Kong - 通讯作者:
Ah-Ng Tony Kong
Potent Inhibitory Effect of δ?Tocopherol on Prostate Cancer Cellsbr /Cultured in Vitro and Grown As Xenograft Tumors in Vivo
生育酚对体外培养的前列腺癌细胞和体内异种移植肿瘤的有效抑制作用
- DOI:
- 发表时间:
2014 - 期刊:
- 影响因子:0
- 作者:
Hong Wang;Zhi Yun Du;Dongli Li;Kun Zhang;Ah-Ng Tony Kong;Robert S. DiPaola;Chung S. Yang;Allan H. Conney;Xi Zheng - 通讯作者:
Xi Zheng
Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells
天然饮食抗癌化学预防化合物:氧化还原介导的正常细胞细胞保护与肿瘤细胞细胞毒性中的差异信号机制
- DOI:
10.1111/j.1745-7254.2007.00549.x - 发表时间:
2007-04-01 - 期刊:
- 影响因子:8.400
- 作者:
Sujit Nair;Wenge Li;Ah-Ng Tony Kong - 通讯作者:
Ah-Ng Tony Kong
Induction of phase I, II and III drug metabolism/transport by xenobiotics
- DOI:
10.1007/bf02977789 - 发表时间:
2005-03-01 - 期刊:
- 影响因子:7.500
- 作者:
Changjiang Xu;Christina Yong-Tao Li;Ah-Ng Tony Kong - 通讯作者:
Ah-Ng Tony Kong
Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis
- DOI:
10.1007/bf02976458 - 发表时间:
2000-02-01 - 期刊:
- 影响因子:7.500
- 作者:
Ah-Ng Tony Kong;Rong Yu;Chi Chen;Sandhya Mandlekar;Thomas Primiano - 通讯作者:
Thomas Primiano
Ah-Ng Tony Kong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ah-Ng Tony Kong', 18)}}的其他基金
Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics
通过 Nrf2 和表观遗传学使用植物化学物质预防皮肤癌
- 批准号:
9207083 - 财政年份:2016
- 资助金额:
$ 44.99万 - 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
- 批准号:
9120455 - 财政年份:2015
- 资助金额:
$ 44.99万 - 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
- 批准号:
9136770 - 财政年份:2015
- 资助金额:
$ 44.99万 - 项目类别:
Epigenetic mechanisms of indole-3-carbinol/diindolylemthane and triterpenoids in prevention of prostate inflammation and related disease
吲哚-3-甲醇/二吲哚柠檬烷和三萜类化合物预防前列腺炎症和相关疾病的表观遗传机制
- 批准号:
9761462 - 财政年份:2015
- 资助金额:
$ 44.99万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8234574 - 财政年份:2012
- 资助金额:
$ 44.99万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8722448 - 财政年份:2012
- 资助金额:
$ 44.99万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
8913687 - 财政年份:2012
- 资助金额:
$ 44.99万 - 项目类别:
Curcuma Longa: epigenetic effects in prostate and colon cancer
姜黄:前列腺癌和结肠癌的表观遗传效应
- 批准号:
9122322 - 财政年份:2012
- 资助金额:
$ 44.99万 - 项目类别:
相似海外基金
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348998 - 财政年份:2025
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Collaborative Research: REU Site: Earth and Planetary Science and Astrophysics REU at the American Museum of Natural History in Collaboration with the City University of New York
合作研究:REU 地点:地球与行星科学和天体物理学 REU 与纽约市立大学合作,位于美国自然历史博物馆
- 批准号:
2348999 - 财政年份:2025
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Collaborative Research: Ionospheric Density Response to American Solar Eclipses Using Coordinated Radio Observations with Modeling Support
合作研究:利用协调射电观测和建模支持对美国日食的电离层密度响应
- 批准号:
2412294 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Conference: Doctoral Consortium at Student Research Workshop at the Annual Conference of the North American Chapter of the Association for Computational Linguistics (NAACL)
会议:计算语言学协会 (NAACL) 北美分会年会学生研究研讨会上的博士联盟
- 批准号:
2415059 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Conference: Polymeric Materials: Science and Engineering Division Centennial Celebration at the Spring 2024 American Chemical Society Meeting
会议:高分子材料:美国化学会 2024 年春季会议科学与工程部百年庆典
- 批准号:
2415569 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346565 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Collaborative Research: RUI: Continental-Scale Study of Jura-Cretaceous Basins and Melanges along the Backbone of the North American Cordillera-A Test of Mesozoic Subduction Models
合作研究:RUI:北美科迪勒拉山脊沿线汝拉-白垩纪盆地和混杂岩的大陆尺度研究——中生代俯冲模型的检验
- 批准号:
2346564 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Conference: Latin American School of Algebraic Geometry
会议:拉丁美洲代数几何学院
- 批准号:
2401164 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant
Conference: North American High Order Methods Con (NAHOMCon)
会议:北美高阶方法大会 (NAHOMCon)
- 批准号:
2333724 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Standard Grant